
Robert J. Bastidas
Articles
-
Feb 15, 2024 |
elifesciences.org | Robert J. Bastidas |Robert Davidson |Stephen Walsh |Lee Dolat
eLife assessment This important study combines state-of-the art proteomics and genetic manipulation of Chlamydia trachomatis to study the function of a chlamydial effector, Cdu1, with deubiquitination and acetylation activities.
-
Oct 30, 2023 |
biorxiv.org | Robert J. Bastidas |Robert Davidson |Stephen Walsh |Lee Dolat
AbstractMany cellular processes are regulated by ubiquitin-mediated proteasomal degradation. Pathogens can regulate eukaryotic proteolysis through the delivery of proteins with de-ubiquitinating (DUB) activities. The obligate intracellular pathogen Chlamydia trachomatis secretes Cdu1 (ChlaDUB1), a dual deubiquitinase and Lys-acetyltransferase, that promotes Golgi remodeling and survival of infected host cells presumably by regulating the ubiquitination of host and bacterial proteins.
-
May 30, 2023 |
pubmed.ncbi.nlm.nih.gov | Robert J. Bastidas |Raphael H. Valdivia |Bastidas RJ |Valdivia RH
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
-
May 22, 2023 |
frontiersin.org | Michael Marceau |David O'Callaghan |Sébastien Bontemps-Gallo |Robert J. Bastidas
Camille M. Riffaud, Elizabeth A. Rucks and Scot P. Ouellette*Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, United StatesIn adapting to the intracellular niche, obligate intracellular bacteria usually undergo a reduction of genome size by eliminating genes not needed for intracellular survival. These losses can include, for example, genes involved in nutrient anabolic pathways or in stress response.
-
Feb 28, 2023 |
biorxiv.org | Robert J. Bastidas |Lee Dolat |Barbara S. Sixt |Jonathan N. Pruneda
Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →